Katherine C Brewer1, Nadine R Peacock2, Carol E Ferrans3,4, Richard T Campbell4,5, Blase Polite6, Leslie Carnahan2,7, Lindsey A Jones1, Garth H Rauscher1,4. 1. Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, Illinois, USA. 2. Division of Community Health Sciences, School of Public Health, University of Illinois at Chicago, Chicago, Illinois, USA. 3. Department of Biobehavioral Health Science, College of Nursing, University of Illinois at Chicago, Chicago, Illinois, USA. 4. Center of Excellence in Eliminating Disparities, University of Illinois at Chicago, Chicago, Illinois, USA. 5. Institute for Health Research and Policy, University of Illinois at Chicago, Chicago, Illinois, USA. 6. Section of Hematology/Oncology, Department of Medicine, University of Chicago Medicine & Biological Sciences, Chicago, Illinois, USA. 7. Center for Research on Women and Gender, College of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.
Abstract
Background: Early detection of colon cancer is essential to successful treatment and survival, yet most patients are diagnosed only after onset of symptoms. Previous studies suggest differences in colon cancer screening and presentation by gender and race, but reasons for this are not understood. The purpose of this study was to identify barriers and facilitators to early detection of colon cancer and to compare by gender and race. Materials and Methods: In the Colon Cancer Patterns of Care in Chicago study, non-Hispanic Black and White (NHB, NHW) patients aged 30-79 newly diagnosed with colon cancer between 2010 and 2014 (n = 249) underwent in-depth semistructured interviews regarding the pathway to colon cancer diagnosis. Mixed qualitative and quantitative methods were used to analyze patient narratives and to compare response patterns by gender and race within prespecified domains: health care access factors, provider-related factors, patient-related factors, and diagnostic workup factors. Results: Women reported more barriers than facilitators to early detection than men (barrier: facilitator ratio of 0.60 vs. 0.48). Thematic differences were seen, with women reporting more barriers related to health care access, scheduling of follow-ups, symptom recognition, and inappropriate or inconclusive diagnostic tests. Fewer women than men reported facilitators related to provider factors such as ease of scheduling follow-ups and receiving referrals for screening or a specialist. NHBs and NHWs reported similar ratios of barriers to facilitators (0.55 vs. 0.53), but more NHBs than NHWs reported barriers related to health care access, scheduling follow-ups, and clinical delays, and fewer NHBs reported facilitators related to health care accessibility (existing relationship with provider, ease of scheduling follow-ups). Conclusions: In this diverse population of patients recently diagnosed with colon cancer, we identified substantive gender- and race-based differences in the types and burden of barriers and facilitators to early detection experienced in the path to diagnosis. These differences should be explored further as they may contribute to disparities in the diagnosis and prognosis of colon cancer.
Background: Early detection of colon cancer is essential to successful treatment and survival, yet most patients are diagnosed only after onset of symptoms. Previous studies suggest differences in colon cancer screening and presentation by gender and race, but reasons for this are not understood. The purpose of this study was to identify barriers and facilitators to early detection of colon cancer and to compare by gender and race. Materials and Methods: In the Colon Cancer Patterns of Care in Chicago study, non-Hispanic Black and White (NHB, NHW) patients aged 30-79 newly diagnosed with colon cancer between 2010 and 2014 (n = 249) underwent in-depth semistructured interviews regarding the pathway to colon cancer diagnosis. Mixed qualitative and quantitative methods were used to analyze patient narratives and to compare response patterns by gender and race within prespecified domains: health care access factors, provider-related factors, patient-related factors, and diagnostic workup factors. Results:Women reported more barriers than facilitators to early detection than men (barrier: facilitator ratio of 0.60 vs. 0.48). Thematic differences were seen, with women reporting more barriers related to health care access, scheduling of follow-ups, symptom recognition, and inappropriate or inconclusive diagnostic tests. Fewer women than men reported facilitators related to provider factors such as ease of scheduling follow-ups and receiving referrals for screening or a specialist. NHBs and NHWs reported similar ratios of barriers to facilitators (0.55 vs. 0.53), but more NHBs than NHWs reported barriers related to health care access, scheduling follow-ups, and clinical delays, and fewer NHBs reported facilitators related to health care accessibility (existing relationship with provider, ease of scheduling follow-ups). Conclusions: In this diverse population of patients recently diagnosed with colon cancer, we identified substantive gender- and race-based differences in the types and burden of barriers and facilitators to early detection experienced in the path to diagnosis. These differences should be explored further as they may contribute to disparities in the diagnosis and prognosis of colon cancer.
Entities:
Keywords:
barriers and facilitators to diagnosis; cancer detection; colon cancer; gender; race
Authors: Carrie N Klabunde; Sally W Vernon; Marion R Nadel; Nancy Breen; Laura C Seeff; Martin L Brown Journal: Med Care Date: 2005-09 Impact factor: 2.983
Authors: Gbenga Ogedegbe; Andrea N Cassells; Christina M Robinson; Katherine DuHamel; Jonathan N Tobin; Carol H Sox; Allen J Dietrich Journal: J Natl Med Assoc Date: 2005-02 Impact factor: 1.798
Authors: Blase N Polite; Toni M Cipriano-Steffens; Fay J Hlubocky; Pascal Jean-Pierre; Ying Cheng; Katherine C Brewer; Garth H Rauscher; George A Fitchett Journal: Cancer Date: 2018-03-26 Impact factor: 6.860
Authors: N Hall; L Birt; J Banks; J Emery; K Mills; M Johnson; G P Rubin; W Hamilton; F M Walter Journal: BMJ Open Date: 2015-10-09 Impact factor: 2.692
Authors: M D Gill; M G Bramble; M A Hull; S J Mills; E Morris; D M Bradburn; Y Bury; C E Parker; T J W Lee; C J Rees Journal: Br J Cancer Date: 2014-09-23 Impact factor: 7.640